Abstract:Originated from Wuhan and expanded throughout China and the world, the 2019 novel coronavirus (COVID-19), has caused worldwide attention. As of March 21, the overall confirmed cases reached to 0.2 million in 172 countries. In all Chinese Medical Centers, elective surgery and the living donor transplantation has been suspended due to the rapid spread of the coronavirus. In contrast, the cadaveric donor transplantations were mostly performed. Therefore, strategies to interrupt transmission within transplantation wards were essential. To date, we have performed at our center ten cases of kidney, four liver and two lung transplants (from deceased organ donors) during the coronavirus outbreak in China (from January 24th to March 11th, 2020). Based on our experience in combating the coronavirus while performing these organ transplants, we comprehensively address here the strategies for the prevention of the virus spread within the transplantation wards. Donor management The potential organ donors were cleared for epidemiology history and should not have traveled from or have contact with people from epidemic areas. Virus nucleic acid from pharyngeal swab specimens was determined, and chest CT was performed. Only when they were confirmed negative for coronavirus, related laboratory tests as HLA typing of donor, antibody detection of the receptor and complement dependent cytotoxicity test could be performed. Recipient management The potential recipients were screened for coronavirus (nucleic acid determination and chest CT scanning) on admission day. Further, additional information was collected from the recipient such as travel history, close contacts, daily body temperature and respiratory symptoms. During the hospitalization period, recipients received COVID-19 related education. Meanwhile, they were given new surgical masks every six hours. We also collaborated with psychologists to provide consultations. Post-transplant immunosuppression was maintained at usual doses. If the recipient had fever, cough, diarrhea or pulmonary infection manifestations, the patient was considered as suspected for contamination and was quarantined within an isolation ward. Accompanying family members of recipients also received COVID-19 related screening as mentioned above. In addition, regular visits were not allowed. Prevention of hospital-acquired infections We implemented strict protocols in preventions of HAIs, including training of HCPs and providing personal protective equipment. Outcome of the organ transplant recipients From January 24th to March 11th, we successfully performed 16 organ transplant operations (10 kidney, 4 liver and 2 lung transplants).

Pasteurized Blood Samples For Transfusion Compatibility Testing During The Coronavirus Disease 2019 Outbreak

Serosurvey for SARS-CoV-2 among Blood Donors in Wuhan,China from September to December 2019

Blood Transfusion During the COVID-19 Outbreak.

Retraction Note To: Methylene Blue Photochemical Treatment As a Reliable SARS-CoV-2 Plasma Virus Inactivation Method for Blood Safety and Convalescent Plasma Therapy for COVID-19

Laboratory Practices to Mitigate Biohazard Risks During the COVID-19 Outbreak: an IFCC Global Survey

Laboratory testing of SARS‐CoV, MERS‐CoV, and SARS‐CoV‐2 (2019‐nCoV): Current status, challenges, and countermeasures

Prevention and Consideration for the Biosafety of Laboratory Testing under Epidemic Condition

Transfusion safety concerns during the COVID-19 pandemic in Taiwan: Altered by evolving control strategies

[Principles and Suggestions on Biosafety Protection of Biological Specimen Preservation During Prevalence of COVID-19].

Prevention and Control Measures in Radiology Department for COVID-19

The influence of sporadic cases of COVID-19 on the work of Transfusion Department and its countermeasures

Treatment of Pancreatic Diseases and Prevention of Infection During Outbreak of 2019 Coronavirus Disease

Analysis of Inactivation of SARS-CoV-2 by Specimen Transport Media, Nucleic Acid Extraction Reagents, Detergents, and Fixatives

Triaging patients in the outbreak of the 2019 novel coronavirus

Biosafety threats of the rapidly established labs for SARS-CoV-2 tests in China

STRATEGIES TO HALT 2019 NOVEL CORONAVIRUS (COVID-19) SPREAD FOR ORGAN TRANSPLANTATION PROGRAMS AT THE SICHUAN ACADEMY OF MEDICAL SCIENCE AND SICHUAN PROVINCIAL PEOPLE’S HOSPITAL, CHINA

Feasibility for SARS-CoV-2 Tests in the Hospital: an Exposure Analysis of Critical Control Points Approach

Operational Considerations and Challenges of Biochemistry Laboratories During the COVID-19 Outbreak: an IFCC Global Survey

Letter: Strategies for Prevention and Control of 2019 Novel Coronavirus Infection Among Medical Staff

Blood routine test in mild and common 2019 coronavirus (COVID-19) patients

Progress in research on the detection of the novel coronavirus in human samples of different groups